Clinical & biological evidence
Clinical questions, multi-omics observations, literature and disease mechanisms.
Home Programmable biology.
OUR SCIENCE
Programmable biology.
Purposeful design.
We organize therapeutic development around the clinical problem, then engineer the biological system that could address it.
THE EBPT APPROACH
A therapeutic is
more than a payload.
Engineered Biological Payload Therapeutics (EBPT) is our framework for developing biological products through four connected design dimensions.
A promising molecule must be paired with a suitable biological chassis, a delivery strategy and an exposure profile. These choices become measurable hypotheses that guide computational evaluation, experiments and process development.
THE BIOLOGICAL INSTRUCTION
What should the product do?
Select a functional payload against a defined mechanism and clinical objective. mRNA can provide a transient instruction for the expression of a therapeutic protein.
DESIGN INPUTS Mechanism · Expression · Biological activity
THE BIOLOGICAL SYSTEM
Which system fits the task?
Select a cell or extracellular-vesicle platform based on the intended function. MSCs, NK cells and EVs have different biological properties and development requirements.
DESIGN INPUTS Identity · Function · Manufacturing consistency
THE SITE OF ACTION
Where should activity occur?
Match the route of administration to the tissue and clinical setting. Local injection, inhalation and other routes require distinct formulation, distribution and safety assessments.
DESIGN INPUTS Target tissue · Route · Biodistribution
THE EXPOSURE PROFILE
How much, and for how long?
Evaluate payload expression, product dose, persistence and repeat administration together. The goal is an exposure profile appropriate to the intended therapeutic window.
DESIGN INPUTS Potency · Dose response · Duration · Safety
CELL AGENT
Better evidence for
the next experiment.
Cell Agent is our developing framework for integrating target evidence, computational evaluation and experimental feedback.
Computational evaluation
Network and pathway evidence, virtual-cell perturbation and dose hypotheses.
Experimental validation
Expression, activity and phenotypic testing, including relevant cellular and organoid models.
Experimental results inform the next design and validation cycle.
Computational predictions guide research decisions. They do not establish clinical safety, efficacy or regulatory approval.
RESEARCH PRIORITIES
Five areas.
One patient-centered purpose.
Musculoskeletal disorders
Cartilage repair, joint preservation and functional recovery.
Metabolic & endocrine disorders
Biological mechanisms relevant to chronic metabolic dysfunction.
Cardiovascular & cerebrovascular disease
Ischemia, vascular regeneration and tissue repair.
Oncology & immune function
Engineered immune-cell approaches and recurrence-related research.
Tissue repair & wound healing
Fibrosis, tissue injury and restoration of function.
CLINICAL CONTEXT
Understanding the need.
Planning the research.
Original website illustrations, July 2026. Labels translated into English.
PARTNER WITH LOTUSLAKE
Science advances
through collaboration.
Bring a clinical challenge, a scientific discovery or a development ambition. Let’s explore what we can build together.
Start a conversation